MK677 Ibutamoren Side Effects

MK677 researcher comparing the data

What’s the Deal with MK-677, Really?

MK-677 is what scientists call a ghrelin receptor agonist and a growth hormone secretagogue. In simpler terms, it basically tricks your body into thinking you’re hungry, which then sparks a release of growth hormone (GH) and IGF-1. Sounds kind of amazing, right? Like just taking a pill and kicking your body’s repair mode into high gear.

But the human body doesn’t usually love shortcuts. And while MK-677 does show a lot of potential in medical settings, it doesn’t come without a list of side effects—some expected, others a bit more under the radar.

Need to know the basics on Ibutamoren? Read our guide here

Why Are We Even Looking Into MK-677?

Believe it or not, this didn’t start in the gym world—it started in the lab. Researchers have been testing MK677 uk as a way to help with muscle wasting, growth hormone deficiencies, and the kind of frailty that comes with age. It’s been looked at in people recovering from hip fractures, older adults in general, and those with pituitary issues. So before we get into the downsides, it’s worth pointing out the original goal: to improve people’s quality of life, not just help them get shredded.

What Side Effects Show Up Most Often (According to Real Data, Not Reddit)?

Let’s break down what clinical studies have found:

A chart comparing weight gain vs appetite with MK677
  1. Bigger Appetite
  • How often? Super common—some studies say nearly everyone feels it.
  • Since MK-677 mimics the hunger hormone (ghrelin), it makes total sense. People in trials talked about intense cravings, and in some cases, that meant unwanted weight gain.
  • For example, one 72-year-old in a study gained over 10 pounds in 16 weeks—mostly from eating more, not muscle growth.
insulinresistancemk677
  1. Temporary Insulin Resistance and Higher Blood Sugar
  • How often? Fairly common.
  • In one Phase II trial with older folks (Friedlander et al., 2001), researchers saw bumps in fasting glucose and mild insulin resistance. Nothing extreme, but still something to watch—especially if you’re at risk for diabetes.
  • One reviewer even joked, “We wanted regeneration and got a little pre-diabetes instead.”
  1. Swelling (Peripheral Edema)
  • Usually shows up in the legs or ankles, due to fluid buildup linked to higher GH and IGF-1 levels. Definitely not ideal for people already dealing with heart issues.
  • How often? Up to 30% in older participants.
  1. Feeling Tired or Sluggish
  • How often? Happens a decent amount.
  • Kind of ironic for something that’s supposed to boost vitality, right? Some people—especially first-timers—reported fatigue or wanting to nap during the day. It could be related to changes in hormone levels or even blood sugar swings. Still needs more research.
  1. Muscle Soreness and Joint Stiffness
  • How often? Not super common, but it happens.
  • This might be due to quick shifts in fluid or sudden rises in IGF-1. No one’s totally sure yet.
  1. Raised Prolactin Levels
  • One study from 2010 noted small increases in prolactin. It’s not fully clear what this means, but higher prolactin can sometimes lead to mood changes, lower libido, or even things like gynecomastia in guys.
  • How often? Rare, but it’s been seen.

Learn more about the studies on MK677 at our research review article here

MK677 Clinical Trial Members

Different Groups, Different Effects

The side effects vary a lot depending on who’s taking it:

  • Older Adults (65+)
    • Appetite goes way up
    • Swelling is pretty common
    • Tiredness shows up a fair bit
    • Blood sugar changes can be more serious
  • Younger Adults (18–45)
    • Appetite still jumps
    • Less fatigue overall
    • Slight rise in blood sugar
    • Prolactin issues are rare
  • People with GH Deficiency
    • They usually handle it better
    • Appetite still climbs
    • Some even see improved blood sugar levels

MK-677 in Real Life: Two Stories

Picture this: A 76-year-old man in Tokyo gets prescribed MK-677 and other SARMS to help bounce back from a fall. He starts feeling more energetic and balanced—but he also finds himself raiding the fridge at midnight and noticing puffy ankles.

Then there’s a 30-year-old woman in Sweden, part of a study on MK-677 and brain health. She reports clearer thinking and deeper sleep, but also starts craving carbs like crazy.

Both experiences highlight the same thing—MK-677 isn’t a one-size-fits-all solution. It can be powerful, but it hits people differently.

The Bigger Picture: What Are We Really Trading?

Interestingly, the side effects of MK-677 vary depending on the population studied. Let’s break it down:

Side EffectElderly Adults (65+)Younger Adults (18-45)GH-Deficient Individuals
Appetite IncreaseAlmost universalHighHigh
Peripheral EdemaModerate to highLowRare
FatigueModerateLowRare
Elevated Blood GlucoseSignificant in someMildSometimes improved
Prolactin ChangesRareRareRare
Muscle/Joint DiscomfortOccasionallyOccasionallyRare
Image showing side effects of MK677 Ibutamoren in the UK

With all the buzz around MK-677—helping with frailty, bone strength, even brain protection—it’s easy to overlook the side effects. But for people already dealing with health challenges, trading one issue (like weak bones) for another (like messed-up blood sugar) isn’t exactly a win.

Regulators are paying attention, too. MK-677 hasn’t been approved for general use yet. Trials are still underway, and the data’s coming in slowly—just like an IV drip in a quiet hospital room.

Scientific References

  1. Friedlander AL et al., 2001 – One-Year Trial of MK-677 in Healthy Older Adults
  2. Chapman IM et al., 1997 – Effects of Oral GH Secretagogue in Elderly Men
  3. Murphy MG et al., 1998 – Effects of MK-677 on GH and IGF-1 Levels
  4. Smith RG et al., 2000 – Ghrelin Receptor Agonists in Clinical Trials
  5. Garcia JM et al., 2010 – Safety and Efficacy of MK-677 in Sarcopenia

Author: Nick Michael TAYLOR

Nick Taylor is a freelance journalist with more than 6 years’ experience of reporting on the global biopharma industry. Since graduating with a biology degree from the University of York, Nick has written for numerous healthcare publications, including Nature BioPharma Dealmakers, Life Science Leader and Outsourcing-Pharm

Checked for Accuracy by John Harling, PhD 15/04/2025